Literature DB >> 7637316

Tumor stroma as a regulator of neoplastic behavior. Agonistic and antagonistic elements embedded in the same connective tissue.

R V Iozzo.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7637316

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


× No keyword cloud information.
  28 in total

1.  Ectopic expression of decorin protein core causes a generalized growth suppression in neoplastic cells of various histogenetic origin and requires endogenous p21, an inhibitor of cyclin-dependent kinases.

Authors:  M Santra; D M Mann; E W Mercer; T Skorski; B Calabretta; R V Iozzo
Journal:  J Clin Invest       Date:  1997-07-01       Impact factor: 14.808

2.  Targeting the cancer stroma with a fibroblast activation protein-activated promelittin protoxin.

Authors:  Aaron M LeBeau; W Nathaniel Brennen; Saurabh Aggarwal; Samuel R Denmeade
Journal:  Mol Cancer Ther       Date:  2009-05-05       Impact factor: 6.261

Review 3.  Significance of tumor-host interactions in cancer growth and metastases.

Authors:  R S Kerbel
Journal:  Cancer Metastasis Rev       Date:  1995-12       Impact factor: 9.264

Review 4.  Dynamics of matrix turnover during pathologic remodeling of the extracellular matrix.

Authors:  W G Stetler-Stevenson
Journal:  Am J Pathol       Date:  1996-05       Impact factor: 4.307

Review 5.  Targeting dormant micrometastases: rationale, evidence to date and clinical implications.

Authors:  Robert E Hurst; Anja Bastian; Lora Bailey-Downs; Michael A Ihnat
Journal:  Ther Adv Med Oncol       Date:  2016-03       Impact factor: 8.168

Review 6.  Endostatin and endorepellin: A common route of action for similar angiostatic cancer avengers.

Authors:  Chiara Poluzzi; Renato V Iozzo; Liliana Schaefer
Journal:  Adv Drug Deliv Rev       Date:  2015-10-27       Impact factor: 15.470

Review 7.  Markers of tumor angiogenesis: clinical applications in prognosis and anti-angiogenic therapy.

Authors:  S B Fox; A L Harris
Journal:  Invest New Drugs       Date:  1997       Impact factor: 3.850

8.  Decorin inhibits the proliferation of HepG2 cells by elevating the expression of transforming growth factor-β receptor II.

Authors:  Yanfeng Liu; Xuesong Wang; Zhaohui Wang; Wenbo Ju; Dawei Wang
Journal:  Exp Ther Med       Date:  2016-08-04       Impact factor: 2.447

9.  Decorin interferes with platelet-derived growth factor receptor signaling in experimental hepatocarcinogenesis.

Authors:  Kornélia Baghy; Zsolt Horváth; Eszter Regős; Katalin Kiss; Zsuzsa Schaff; Renato V Iozzo; Ilona Kovalszky
Journal:  FEBS J       Date:  2013-03-25       Impact factor: 5.542

10.  Photodynamic molecular beacon triggered by fibroblast activation protein on cancer-associated fibroblasts for diagnosis and treatment of epithelial cancers.

Authors:  Pui-Chi Lo; Juan Chen; Klara Stefflova; Michael S Warren; Roya Navab; Bizhan Bandarchi; Stefanie Mullins; Ming Tsao; Jonathan D Cheng; Gang Zheng
Journal:  J Med Chem       Date:  2009-01-22       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.